Difference between revisions of "2011 EHR Quality Measure Spec 0068"
Peterbodtke (talk | contribs) |
(Added a glossary link to Action~) |
||
| Line 50: | Line 50: | ||
'''DEVELOPMENT STATUS''' (Add details here) | '''DEVELOPMENT STATUS''' (Add details here) | ||
| − | '''ACTION ITEMS / NEXT STEPS''' (Add details here) | + | '''[[ACTION~|Action]] ITEMS / NEXT STEPS''' (Add details here) |
'''PREPARE CERTIFICATION DOCUMENTATION''' (Add details here) | '''PREPARE CERTIFICATION DOCUMENTATION''' (Add details here) | ||
'''OPEN ISSUES / QUESTIONS''' (Add details here) | '''OPEN ISSUES / QUESTIONS''' (Add details here) | ||
Latest revision as of 22:12, 29 July 2012
MEASURE # 0068
MEASURE TITLE Ischemic Vascular Disease (IVD): Use of Aspirin or another Antithrombotic
MEASURE DESCRIPTION The percentage of patients 18 years of age and older who were discharged alive for acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous transluminal coronary angioplasty (PTCA) from January 1–November 1 of the year prior to the measurement year, or who had a diagnosis of ischemic vascular disease (IVD) during the measurement year and the year prior to the measurement year and who had documentation of use of aspirin or another antithrombotic during the measurement year.
Documents for 2011 EHR-Based Reporting
SPREADSHEET NQF_Retooled_Measure_0068.xlsx
SPREADSHEET GOOGLE DOC URL (editable) http://spreadsheets.google.com/a/worldvista.org/ccc?key=0ArxIkIV4NePEdGdtMG42UW1qNUR6ZU1xcWN2NW9NRkE&hl=en&authkey=CKmFlJgC
PDF FILE NAME NQF_HQMF_HumanReadable_0068.pdf
PDF FILE URL https://docs.google.com/fileview?id=1w4NJ2wXE1CCy0I_0adEX3SCA9xKZ66wseC90S2xBlhicZIJkmhajwPo-f3ln&hl=en
REGARDING MULTIPLE NUMERATORS N/A
| TARGET DATE | SOLUTION DEVELOPERS | STATUS | SPEC DEVELOPER | NUMERATOR(s) | DENOMINATOR(s) |
|---|---|---|---|---|---|
| Phase II | TBD | N/A | NCQA | 1 | 1 |
SOLUTION DESIGN / TECHNOLOGY (Add details here)
SOLUTION COMPONENTS (Add details here)
DEPENDENCIES (Add details here)
COMMENTS / NOTES (Add details here)
DEVELOPMENT STATUS (Add details here)
Action ITEMS / NEXT STEPS (Add details here)
PREPARE CERTIFICATION DOCUMENTATION (Add details here)
OPEN ISSUES / QUESTIONS (Add details here)
